Add to ORKGAssessing the risk of osteonecrosis of the jaw due to bisphosphonate therapy in the secondary prevention of osteoporotic fracture
BACKGROUND Bisphosphonates are anti-resorptive agents that have been used for more than a decade, f...
An Editorial in the June 2008 issue of the Irish Medical Journal (IMJ) entitled âTreating Osteoporos...
Abstract: Bisphosphonates are important drugs that are increasingly prescribed to reduce the morbidi...
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the ...
There is evidence that the use oral bisphosphonates can lead to osteronecrosis of the jaws (ONJ). Al...
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, p...
There is evidence that the use oral bisphosphonates can lead to osteronecrosis of the jaws (ONJ). Al...
Since four years from now on more and more information about bisphosphonate induced osteonecrosis of...
Bisphosphonates are potent inhibitors of osteoclast activity that reduce bone turnover and re-establ...
Journal Article;Bisphosphonates (BP) are a type of drug known to inhibit bone resorption through com...
Introduction: Clinical trials indicate that oral BP reduce the incidence of osteoporotic fractures ...
Copyright © 2014 Eder Alberto Sigua-Rodriguez et al. This is an open access article distributed unde...
Osteonecrosis of the jaws is a recently described adverse side effect of bisphosphonate therapy. Pat...
a b s t r a c t Objective: To systematically assess the literature related to the occurrence of oste...
Osteonecrosis of the jaws is a recently described adverse side effect of bisphosphonate therapy. Pat...
BACKGROUND Bisphosphonates are anti-resorptive agents that have been used for more than a decade, f...
An Editorial in the June 2008 issue of the Irish Medical Journal (IMJ) entitled âTreating Osteoporos...
Abstract: Bisphosphonates are important drugs that are increasingly prescribed to reduce the morbidi...
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the ...
There is evidence that the use oral bisphosphonates can lead to osteronecrosis of the jaws (ONJ). Al...
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, p...
There is evidence that the use oral bisphosphonates can lead to osteronecrosis of the jaws (ONJ). Al...
Since four years from now on more and more information about bisphosphonate induced osteonecrosis of...
Bisphosphonates are potent inhibitors of osteoclast activity that reduce bone turnover and re-establ...
Journal Article;Bisphosphonates (BP) are a type of drug known to inhibit bone resorption through com...
Introduction: Clinical trials indicate that oral BP reduce the incidence of osteoporotic fractures ...
Copyright © 2014 Eder Alberto Sigua-Rodriguez et al. This is an open access article distributed unde...
Osteonecrosis of the jaws is a recently described adverse side effect of bisphosphonate therapy. Pat...
a b s t r a c t Objective: To systematically assess the literature related to the occurrence of oste...
Osteonecrosis of the jaws is a recently described adverse side effect of bisphosphonate therapy. Pat...
BACKGROUND Bisphosphonates are anti-resorptive agents that have been used for more than a decade, f...
An Editorial in the June 2008 issue of the Irish Medical Journal (IMJ) entitled âTreating Osteoporos...
Abstract: Bisphosphonates are important drugs that are increasingly prescribed to reduce the morbidi...